Table 4. Medication use over time in patients with device implanted and completed follow-up compared with baseline (using available paired data).
Medication at baseline (pre-procedure) | |||||||
---|---|---|---|---|---|---|---|
Antiplatelet only | Anti-coagulant | Other (incl. None) | Antiplatelet only | Anti-coagulant | Other (incl. None) | p-value | |
Discharge (n = 863) | 697 (80.8%) | 88 (10.2%) | 78 (9.0%) | 766 (88.8%) | 48 (5.6%) | 49 (5.7%) | p<0.0001 |
6 weeks (n = 632) | 527 (83.4%) | 27 (4.3%) | 78 (12.3%) | 527 (83.4%) | 33 (5.2%) | 72 (11.4%) | 0.65 |
6 months (n = 531) | 436 (82.1%) | 17 (3.2%) | 78 (14.7%) | 436 (82.1%) | 27 (5.1%) | 68 (12.8%) | 0.23 |
1 year (n = 350) | 262 (74.9%) | 10 (2.9%) | 78 (22.3%) | 262 (74.9%) | 16 (4.6%) | 72 (20.6%) | 0.46 |
2 years (n = 104) | 70 (67.3%) | 0 (0%) | 34 (32.7%) | 70 (67.3%) | 4 (3.8%) | 30 (28.8%) | 0.15 |